Mother - Daughter Initiative (MDI) in Cervical Cancer Prevention

Jhpiego

Status

Completed

Conditions

Cervical Cancer

Treatments

Biological: HPV Vaccine (Gardasil)

Study type

Interventional

Funder types

Other

Industry

Identifiers

NCT01096134

36448

Details and patient eligibility

About

The Mother-Daughter Initiative (MDI) will test the feasibility and acceptability of a strategy to deliver comprehensive cervical cancer prevention services in Thailand and the Philippines by integrating the HPV vaccine for girls ages 9-13 into already successful screening and treatment programs for mothers.

Enrollment

8,000 patients

Sex

Female

Ages

9 to 13 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Age 9-13 at first HPV vaccine dose
Mother/legal guardian and daughter are both interested and willing to have the girl receive the HPV vaccine
Mother/legal guardian and daughter both indicate that they would be able to return to clinic for the three vaccine doses

Exclusion criteria

Girls with a known history of any allergies or severe reaction to any vaccines, food or medicine
Pregnant adolescents will be excluded. If a girl becomes pregnant after the first dose is administered, she will not be provided with the second or third dose
Girls with moderate or severe illnesses will be asked to postpone vaccination eg. Pneumonia.
Girls with a weakened immune system, cancer, leukemia, AIDS or other immune system problems
Girls with a bleeding disorder or currently taking anticoagulants
Girls that have received any other vaccinations in the past 4 weeks
Girls currently on steroids, such as cortisone, prednisone, or anti-cancer drug.